Control Bionics Limited (CBL.AX)

0,0430 0,0000 (0,00%) Börsenschluss: 01:20PM AEST

Control Bionics Limited

697 Bourke Road
Level 5, Suite 5.01
Camberwell, VIC 3124
Australia
61 3 9897 3576
https://www.controlbionics.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Jeremy E. Steele	CEO, MD & Director	363,72k	N/A	N/A
Mr. Peter Shann Ford	Founder & Non-Executive Director	215,75k	N/A	N/A
Mr. Dominik Kucera	Interim Chief Financial Officer	373,96k	N/A	N/A
Mr. James Schorey	Chief Technology Officer	N/A	N/A	N/A
Ms. Meagan Koeneman	Sales Director	N/A	N/A	N/A
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw	Company Secretary	N/A	N/A	1957

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in AUD.

Beschreibung

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.

Corporate Governance

Control Bionics Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.